Sreedhar Thirumala, PhD, is a senior leader in cell and gene therapy with over 15 years of experience in end-to-end process development, characterization, and drug product formulation. He currently leads Drug Product Development for cell therapy programs at Genentech. His expertise spans viral and non-viral gene editing platforms, scalable manufacturing, cryopreservation, and fill-finish, driving phase-appropriate CMC strategies from early development through clinical readiness. Dr. Thirumala is recognized for translating complex technologies into robust, regulator-ready manufacturing platforms. His work ensures cutting-edge treatments are developed with an eye toward manufacturability, quality, and regulatory compliance, accelerating their path from bench to bedside.